HC Wainwright initiates iBio coverage with Buy rating, $7 target
HC Wainwright & Co. initiated coverage of iBio with a Buy rating and a $7.00 price target, implying 493.2% upside versus the Sep 16 close of $1.18.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.